The Scientist

» clinical trials and ecology

Most Recent

image: More Details on How Pesticides Harm Bees

More Details on How Pesticides Harm Bees

By | May 3, 2017

Scientists report that thiamethoxam exposure impairs bumblebees’ reproduction and honey bees’ ability to fly.

0 Comments

From fish harvests to cottonwood forests, organisms display evidence that species change can occur on timescales that can influence ecological processes.

5 Comments

Guppies transplanted between different communities in Trinidadian streams evolved in response to changes in predation threat in just a few generations.

1 Comment

image: Cell Lines Gain Cancer-Related Mutations

Cell Lines Gain Cancer-Related Mutations

By | April 27, 2017

A screen of human embryonic stem cell lines finds several that accumulated changes in the gene TP53, including aberrations commonly seen in cancer.

0 Comments

image: Migratory Eels Use Magnetoreception

Migratory Eels Use Magnetoreception

By | April 14, 2017

In laboratory experiments that simulated oceanic conditions, the fish responded to magnetic fields, a sensory input that may aid migration.

0 Comments

image: DNA-Based Zika Vaccine Reaches Phase 2

DNA-Based Zika Vaccine Reaches Phase 2

By | April 4, 2017

An NIAID-sponsored clinical trial advances beyond safety testing.

0 Comments

At the annual American Association for Cancer Research meeting, researchers discuss the importance of understanding the epigenetic contributors to cancer progression and treatment response.

0 Comments

image: Rethinking a Cancer Drug Target

Rethinking a Cancer Drug Target

By | March 26, 2017

The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

0 Comments

image: Women Lose Vision After Stem Cell Treatment

Women Lose Vision After Stem Cell Treatment

By | March 17, 2017

The adipose-derived cells were injected into the patients’ eyes to treat age-related macular degeneration. 

1 Comment

image: Kite’s CAR T-Cell Therapy Success

Kite’s CAR T-Cell Therapy Success

By | March 1, 2017

More than one-third of lymphoma patients in a Phase 2 trial were clear of disease at six months, and no new safety concerns arose since the company’s three-month follow up.

0 Comments

Popular Now

  1. Man Receives First In Vivo Gene-Editing Therapy
  2. Long-term Study Finds That the Pesticide Glyphosate Does Not Cause Cancer
  3. Researchers Build a Cancer Immunotherapy Without Immune Cells
  4. Research Links Gut Health to Neurodegeneration
    The Nutshell Research Links Gut Health to Neurodegeneration

    Rodent studies presented at the Society for Neuroscience meeting this week tie pathologies in the gastrointestinal tract or microbiome composition with Parkinson’s and Alzheimer’s diseases.

RayBiotech